Holen Sie sich die Stockscreener-App
1.73
2.37%
0.04
Handel nachbörslich:
1.75
0.02
+1.16%
Schlusskurs vom Vortag:
$1.69
Offen:
$1.7
24-Stunden-Volumen:
151.52K
Relative Volume:
0.61
Marktkapitalisierung:
$10.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.23M
KGV:
-1.4095
EPS:
-1.2274
Netto-Cashflow:
$-10.29M
1W Leistung:
+10.19%
1M Leistung:
-13.50%
6M Leistung:
-79.28%
1J Leistung:
-91.52%
1-Tages-Spanne:
$1.66
$1.7899
1-Wochen-Bereich:
$1.50
$1.7899
52-Wochen-Spanne:
$1.50
$42.92
Seastar Medical Holding Corp Stock (ICU) Company Profile
Firmenname
Seastar Medical Holding Corp
Sektor
Branche
Telefon
844-427-8100
Adresse
3513 BRIGHTON BLVD, DENVER
Vergleichen Sie ICU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICU
Seastar Medical Holding Corp
|
1.73 | 10.02M | 0 | -26.23M | -10.29M | -1.2274 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Seastar Medical Holding Corp Aktie (ICU) Neueste Nachrichten
SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE - GlobeNewswire
ICU News Today | Why did SeaStar Medical stock go up today? - MarketBeat
SeaStar Shares Static Ahead of Drug Trials - Baystreet.ca
SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial - GlobeNewswire
SeaStar Medical says FDA approves feasibility study with SCD-ADULT - Yahoo Finance
SeaStar Medical Gains FDA Approval for Pediatric Device - TipRanks
FDA Approves Feasibility Study with SeaStar Medical’s - GlobeNewswire
SeaStar Medical Secures FDA Approval for Breakthrough Heart Failure Treatment Study - StockTitan
SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer - GlobeNewswire
Seastar Medical Begins Shipping Quelimmune to A Fourth Hospital Customer - Marketscreener.com
AtriCure (NASDAQ:ATRC) versus SeaStar Medical (NASDAQ:ICU) Critical Contrast - Defense World
Financial Review: Globus Medical (NYSE:GMED) vs. SeaStar Medical (NASDAQ:ICU) - Defense World
ICUSeaStar Medical Holding Corporation Latest Stock News & Market Updates - StockTitan
SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial - GlobeNewswire
SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial - GlobeNewswire Inc.
Analyzing SeaStar Medical (NASDAQ:ICU) & Aethlon Medical (NASDAQ:AEMD) - Defense World
SEASTAR ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
ICU stock hits 52-week low at $1.82 amid market challenges - Investing.com
Medical Device Co. Brass Hid SPAC's True Value, Suit Says - Law360
SeaStar Medical Projects Multibillion-Dollar Market - GlobeNewswire
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024 - GlobeNewswire
SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial - GlobeNewswire
SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune - Investing.com Nigeria
SeaStar Medical (NASDAQ:ICU) Trading Down 1.6% – What’s Next? - Defense World
SeaStar Medical reduces authorized shares By Investing.com - Investing.com Canada
SeaStar Medical reduces authorized shares - Investing.com
SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024 - GlobeNewswire
SeaStar Medical to Present at NobleCon20 Conference on Hyperinflammation Solutions | ICU Stock News - StockTitan
Leading Independent Proxy Advisory Firms ISS and Glass - GlobeNewswire
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares - Quantisnow
SeaStar Medical chief medical officer purchases $8,457 in stock By Investing.com - Investing.com Australia
SeaStar Medical chief medical officer purchases $8,457 in stock - Investing.com
Seastar Soars On Latest Tidings - MENAFN.COM
SeaStar Soars on Latest Tidings - Baystreet.ca
SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer - Yahoo Finance
SeaStar Medical reports net revenue of USD 67,500 in Q3 2024 - Medical Buyer
SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update - Yahoo Finance
Half of Patients Now Enrolled in SeaStar Medical’s NEUTRALIZE-AKI Trial - MPO-mag
Critical Analysis: Merit Medical Systems (NASDAQ:MMSI) and SeaStar Medical (NASDAQ:ICU) - Defense World
SeaStar Medical (NASDAQ:ICU) Trading Down 3% – Here’s What Happened - Defense World
FDA grants breakthrough status to SeaStar Medical's SCD - Investing.com
FDA Grants Breakthrough Device Designation for SeaStar - GlobeNewswire
FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis - Yahoo Finance
Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial - GlobeNewswire
SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE - Yahoo Finance
Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024Update - Yahoo Finance
Finanzdaten der Seastar Medical Holding Corp-Aktie (ICU)
Umsatz
Nettogewinn
Free Cashflow
ENV
Seastar Medical Holding Corp-Aktie (ICU) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Chung Kevin | Chief Medical Officer |
Sep 30 '24 |
Buy |
4.26 |
1,000 |
4,258 |
9,435 |
5.49%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):